Yuji Inagaki

Dr. Yuji Inagaki

Department of Periodontology and Endodontology, Institute of Biomedical Sciences, Tokushima University Graduate School

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
YUYUTA UEMURA
YUTA UEMURA
YHYuka Hiroshima
Yuka Hiroshima
ATAyano Tada
Ayano Tada
KMKeiji Murakami
Keiji Murakami
KYKayo Yoshida
Kayo Yoshida
HYHiromichi Yumoto
Hiromichi Yumoto
Porphyromonas gingivalis (Pg) is a keystone pathogen associated with chronic periodontitis and produces outer membrane vesicles (OMVs) that contain lipopolysaccharide (LPS), gingipains, and pathogen-derived DNA and RNA. Pg-OMVs are involved in the pathogenesis of periodontitis. Pg-OMV-activated pathways that induce the production of the pro-inflammatory cytokines, interleukin (IL)-6, and IL-8 in the human gingival epithelial cell line, OBA-9, were investigated. The role of mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB in levels of Pg-OMV-induced pro-inflammatory cytokines was investigated using Western blot analysis and specific pathway inhibitors. Pg-OMVs induced IL-6 and IL-8 production via the extracellular signal-regulated kinase (Erk) 1/2, c-Jun N-terminal kinase (JNK), p38 MAPK, and NF-κB signaling pathways in OBA-9 cells. In addition, the stimulator of interferon genes (STING), an essential innate immune signaling molecule, was triggered by a cytosolic pathogen DNA. Pg-OMV-induced IL-6 and IL-8 mRNA expression and production were significantly suppressed by STING-specific small interfering RNA. Taken together, these results demonstrated that Pg-OMV-activated Erk1/2, JNK, p38 MAPK, STING, and NF-κB signaling pathways resulting in increased IL-6 and IL-8 expression in human gingival epithelial cells. These results suggest that Pg-OMVs may play important roles in periodontitis exacerbation by stimulating various pathways.

15 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
KNKohei Nonaka
Kohei Nonaka
MBMika Bando
Mika Bando
ESEijiro Sakamoto
Eijiro Sakamoto
YIYuji Inagaki
Yuji Inagaki
KNKoji Naruishi
Koji Naruishi
JKJun-ichi Kido
Jun-ichi Kido
Advanced glycation end-products (AGEs) cause diabetes mellitus (DM) complications and accumulate more highly in periodontal tissues of patients with periodontitis and DM. AGEs aggravate periodontitis with DM by increasing the expression of inflammation-related factors in periodontal tissues. 6-Shogaol, a major compound in ginger, has anti-inflammatory and anti-oxidative activities. However, the influence of shogaol on DM-associated periodontitis is not well known. In this study, the effects of 6-shogaol on AGEs-induced oxidative and anti-oxidative responses, and IL-6 and ICAM-1 expression in human gingival fibroblasts (HGFs) were investigated. When HGFs were cultured with 6-shogaol and AGEs, the activities of reactive oxygen species (ROS) and antioxidant enzymes (heme oxygenase-1 [HO-1] and NAD(P)H quinone dehydrogenase 1 [NQO1]), and IL-6 and ICAM-1 expressions were investigated. RAGE expression and phosphorylation of MAPKs and NF-κB were examined by western blotting. 6-Shogaol significantly inhibited AGEs-induced ROS activity, and increased HO-1 and NQO1 levels compared with the AGEs-treated cells. The AGEs-stimulated expression levels of receptor of AGE (RAGE), IL-6 and ICAM-1 and the phosphorylation of p38, ERK and p65 were attenuated by 6-shogaol. These results suggested that 6-shogaol inhibits AGEs-induced inflammatory responses by regulating oxidative and anti-oxidative activities and may have protective effects on periodontitis with DM.

20 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YIYuji Inagaki
Yuji Inagaki
JKJun-ichi Kido
Jun-ichi Kido
YNYasufumi Nishikawa
Yasufumi Nishikawa
RKRie Kido
Rie Kido
ESEijiro Sakamoto
Eijiro Sakamoto
HYHiromichi Yumoto
Hiromichi Yumoto
Gan-Lu-Yin (GLY), a traditional Chinese herbal medicine, shows therapeutic effects on periodontitis, but that mechanism is not well known. This study aims to clarify the precise mechanism by investigating the inhibitory effects of GLY extracts on osteoclastogenesis in vitro and on bone resorption in periodontitis in vivo. RAW264.7 cells are cultured with soluble receptor activator of nuclear factor-kappa B (sRANKL) and GLY extracts (0.01–1.0 mg/mL), and stained for tartrate-resistant acid phosphatase (TRAP) to evaluate osteoclast differentiation. Experimental periodontitis is induced by placing a nylon ligature around the second maxillary molar in rats, and rats are administered GLY extracts (60 mg/kg) daily for 20 days. Their maxillae are collected on day 4 and 20, and the levels of alveolar bone resorption and osteoclast differentiation are estimated using micro-computed tomography (CT) and histological analysis, respectively. In RAW264.7 cells, GLY extracts significantly inhibit sRANKL-induced osteoclast differentiation at a concentration of more than 0.05 mg/mL. In experimental periodontitis, administering GLY extracts significantly decreases the number of TRAP-positive osteoclasts in the alveolar bone on day 4, and significantly inhibits the ligature-induced bone resorption on day 20. These results show that GLY extracts suppress bone resorption by inhibiting osteoclast differentiation in experimental periodontitis, suggesting that GLY extracts are potentially useful for oral care in periodontitis.

5 April 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DNDaisuke Nakamura
Daisuke Nakamura
YIYuji Inagaki
Yuji Inagaki
YUYuta Uemura
Yuta Uemura
YHYuka Hiroshima
Yuka Hiroshima
YIYoshimune Iwata
Yoshimune Iwata
HYHiromichi Yumoto
Hiromichi Yumoto
Outer membrane vesicles (OMVs) released by bacteria contain bacteria-specific nucleic acids and proteins. Porphyromonas gingivalis ( Pg )-OMVs exert various effects on periodontal tissue cells; however, their involvement in bone metabolism remains unclear. Therefore, this study aimed to investigate the effects of Pg -OMVs on osteoclasts and osteoblasts in vitro and elucidate their involvement in alveolar bone resorption in vivo using experimental periodontitis model rats. Tartrate-resistant acid phosphatase staining and Western blotting revealed that Pg -OMVs promoted osteoclast differentiation and increased the levels of several osteoclast differentiation markers, respectively, in RAW264.7 cells. Quantitative reverse transcription-polymerase chain reaction and Western blotting revealed that Pg -OMVs increased the receptor activator of nuclear factor-kappa B (NF-κB) ligand (RANKL) levels and decreased osteoprotegerin (OPG) levels in MC3T3-E1 cells. Pg -OMVs reduced alkaline phosphatase activity and calcified nodule formation in a concentration-dependent manner. Rats were divided into four groups (healthy control, Pg -OMV administration, ligature-induced periodontitis, and ligature-induced periodontitis with Pg -OMV administration groups), and the alveolar bone resorption degree was measured via micro-computed tomography. Pg -OMVs administration significantly promoted alveolar bone resorption and increased the RANKL/OPG ratio in periodontal tissues. Our results suggest that Pg -OMVs contribute to alveolar bone resorption by promoting osteoclast differentiation, suppressing osteoblast mineralization, and increasing the RANKL/OPG ratio.

30 June 2025 in Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology)
Verified
Journal Article
Open access
PDF file
YIYuji Inagaki
Yuji Inagaki
DNDaisuke Nakamura
Daisuke Nakamura
YIYoshimune Iwata
Yoshimune Iwata
YUYuta Uemura
Yuta Uemura
HYHiromichi Yumoto
Hiromichi Yumoto